Built for small pharma

The infrastructure small pharma actually needs.

Graticus gives small and emerging pharma companies the tools, training, and strategic support that were previously only available to large enterprises — purpose-built for teams with real science and limited bandwidth.

Protocol Generator Training AdvisoryEst. 2026 · Small Pharma
01 / Services

Three offerings. One firm. Built around what small pharma teams actually face.

01 · Protocol Generator

A development brief, from a structure to a document.

Identify a compound by name, by uploading a structure, or by drawing it. The Protocol Generator gathers the evidence — chemistry, literature, trials, patents — builds a cited register, and writes a development brief you can put in front of a partner.

  • Development briefs with a full citation register
  • Synthesis, SOP, stability and safety protocols
  • Add project plans, valuation, or finance tracking
  • Or take the whole dashboard — regulatory, IP, vendors, data room
Request access
02 · Training

Make the expensive decisions first in a simulation.

Thirteen decision simulations that put your team in the chair — a runway, a molecule, and a call to make. Teaching comes before the decision and the reasoning comes after it, so people learn why the strong answer was strong.

  • Founder track — regulatory, licensing, capital, exit
  • Technology transfer track — written from the TTO side of the table
  • Or the full catalogue, thirteen simulations
  • Priced by the seat, and tailorable to your own programme
Sign in
03 · Advisory

Strategic support when the decisions are hardest.

A small number of engagements at a time, on licensing strategy, partnership structuring, regulatory planning and commercial execution — from a team that has built and transacted in pharma.

  • Licensing and out-licensing strategy
  • Partner identification and deal structuring
  • Regulatory and commercial pathway planning
  • Interim leadership and fractional CBDO support

Deliberately limited. We take on few engagements so the ones we take on get the room.

Enquire
02 / Approach

The name we chose is the standard we hold.

01

Graticule — we measure before we advise.

A graticule is the crosshair inside a microscope. It is the quiet instrument by which something small becomes legible. We begin every engagement the same way: by looking carefully at where you actually are, not where you want to be.

02

Small pharma deserves enterprise-grade support.

The tools and counsel that move molecules to market have historically been available only to large organizations. We built Graticus to close that gap — because the best science is not always inside the largest companies.

03

Invictus — we hold the line when the work gets difficult.

Programs stall. Funding tightens. Partners go quiet. Our value is highest at the exact moment most advisors become scarce. We stay in the room and do the work until the outcome is resolved.

04

Tools and strategy are not separable.

The tools are not products we license and leave. They are integrated into how we advise — so the intelligence your team builds inside them directly informs every strategic conversation we have together. Equally, each stands on its own: most customers take one and never need the rest.

03 / Industries

We work with small and emerging pharma companies at every stage of growth.

01
Pre-clinical & Early Stage
02
Clinical-Stage Biotech
03
Specialty Pharma
04
Drug Delivery Platforms
05
Nutraceutical & OTC
06
505(b)(2) Programs
07
Licensing & Out-licensing
08
Emerging Market Pharma
Precision is a kind of respect. It is the only way to honor the science — and the patients waiting at the end of it.
Graticus · Founding Principle

Start a conversation.

Tell us about your pipeline, your team, and the decision in front of you. We respond within two business days — usually faster.

hello@graticus.com